Reference number : GC-2017-Q1-01139, amendment number : , agreement type : G, recipient legal name : Beauger, Nadine (Institute for Research in Immunology and Cancer CECR in Therapeutics Discovery)|Beauger, Nadine (Institut de recherche en immunologie et en cancérologie IRIC), recipient country : CA, recipient province : nan, recipient city : Quebec|Québec, recipient postal code : nan, program name english : Centres of Excellence for Commercialization and Research - Letters of Intent, program name french : Centres d'excellence en commercialisation et en recherche - lettres d'intention, program purpose english : nan, program purpose french : nan, agreement title english : Institute for Research in Immunology and Cancer - Commercialization of Research (IRICOR), agreement title french : Institute for Research in Immunology and Cancer - Commercialization of Research (IRICOR), agreement number : CECLI, agreement value : 15000.0, agreement start date : 2017-06-14, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year. (2017-2018 to 2018-2019), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier. (2017-2018 à 2018-2019), owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada